Kala is an exciting biopharmaceutical company focused on development and commercialization of therapeutics using our proprietary nanoparticle‑based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Our growing team is passionate about our MPP technology and developing innovative and important therapies for patients with eye diseases. We are proud of our smart and committed team and are seeking talented and passionate individuals who thrive in a fast-paced and dynamic team environment.
Kala Pharmaceuticals is an Equal Opportunity Employer that offers a competitive and comprehensive employee benefits package.
Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary mucus-penetrating particle (MPP) technology, with an initial focus on the treatment of eye diseases.
Our MPPs are selectively-sized nanoparticles and have proprietary coatings. We believe that these two key attributes enable even distribution of drug particles on mucosal surfaces and significantly increase drug delivery to target tissues by enhancing mobility of drug particles through mucus and preventing drug particles from becoming trapped and eliminated by mucus.
We have applied the MPP technology to create nanosuspensions of loteprednol etabonate, or LE, a corticosteroid designed for ocular applications, resulting in our two lead product candidates; INVELTYS™ (KPI-121 1.0%) for the treatment of inflammation and pain following ocular surgery and KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease.